Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9755)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2021 (publication date) through Jul 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sampaio MM, Santos MLC, Marques HS, Gonçalves VLS, Araújo GRL, Lopes LW, Apolonio JS, Silva CS, Santos LKS, Cuzzuol BR, Guimarães QES, Santos MN, de Brito BB, da Silva FAF, Oliveira MV, Souza CL, de Melo FF. Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review. World J Clin Oncol 2021; 12(2): 69-94 [PMID: 33680875 DOI: 10.5306/wjco.v12.i2.69] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i2/69.htm |
| Number | Citing Articles |
| 1 |
Tyler Medina, Seán O. Hynes, Maeve Lowery, Paddy Gillespie, Walter Kolch, Cathal Seoighe. Overview of Molecular Diagnostics in Irish Clinical Oncology. HRB Open Research 2024; 7: 16 doi: 10.12688/hrbopenres.13822.1
|
| 2 |
Dean G. Brown. A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. Journal of Medicinal Chemistry 2024; doi: 10.1021/acs.jmedchem.3c02165
|
| 3 |
Dena Panovska, Frederik De Smet. Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?. International Journal of Molecular Sciences 2022; 23(15): 8637 doi: 10.3390/ijms23158637
|
| 4 |
Alyaa Mohamed Ghoneem, Eman A. Soliman, Shaimaa El-Ashwah, Mohammed El Agdar, Hasan Abdel-Ghaffar. Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia. Egyptian Journal of Basic and Applied Sciences 2024; 11(1): 84 doi: 10.1080/2314808X.2024.2317021
|
| 5 |
Alice de Freitas Gomes, Adriane Dâmares de Souza Jorge Batalha, Carlos Eduardo de Castro Alves, Renata Galvão de Azevedo, Jesus Rafael Rodriguez Amado, Tatiane Pereira de Souza, Hector Henrique Ferreira Koolen, Felipe Moura Araújo da Silva, Francisco Celio Maia Chaves, Serafim Florentino Neto, Antônio Luiz Boechat, Gemilson Soares Pontes. Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia. Pharmaceutics 2024; 16(6): 828 doi: 10.3390/pharmaceutics16060828
|
| 6 |
Shalmali Pendse, Sayali Chavan, Vaijayanti Kale, Anuradha Vaidya. A comprehensive analysis of cell‐autonomous and non‐cell‐autonomous regulation of myeloid leukemic cells: The prospect of developing novel niche‐targeting therapies. Cell Biology International 2023; 47(10): 1667 doi: 10.1002/cbin.12078
|
| 7 |
Kavita Sangwan, Suman Khurana, Pratibha Dhakla. Imatinib Analogs in Chronic Myeloid Leukemia: a Systematic Qualitative Review. Current Pharmacology Reports 2023; 9(3): 99 doi: 10.1007/s40495-023-00316-0
|
| 8 |
Ahmad Mir Hosseini, Shiva Dianaty, Sara Shahhosseini, Reza Biglarifard, Razieh Razmi, Nima Komeili, Danial Soltani. Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies. Journal of Lab Animal Research 2023; 2(6): 86 doi: 10.58803/jlar.v2i6.34
|
| 9 |
Fadwa M. AlKhulaifi, Afrah Alkhuriji, Lamjed Mansour, Abdullah Al-jurayyan, Norah M.A. Al-Mulhim, Yusra A. Tashkandy, Ghadeer S. Aldossari, Suliman Alomar. Association between Toll-like receptor 4 polymorphism and Acute Lymphoblastic Leukemia susceptibility in Saudi Arabian patients. Journal of King Saud University - Science 2022; 34(4): 101985 doi: 10.1016/j.jksus.2022.101985
|
| 10 |
Biswajit Bhuyan, Somanath Padhi, Probodha Kumar Das, Chinmayee Panigrahi. Leukemia - From Biology to Clinic. 2023; doi: 10.5772/intechopen.108334
|
| 11 |
D. Yahya, V. Miteva, I. Micheva, T. Ruseva, L. Angelova. Cytogenetic Analysis of Patients with Hematological Malignancies. Cytology and Genetics 2023; 57(3): 272 doi: 10.3103/S0095452723030106
|
| 12 |
Kasumi Satoh, Saori Morisawa, Manabu Okuyama, Hajime Nakae. Severe pleural effusion associated with nilotinib for chronic myeloid leukaemia: cross-intolerance with tyrosine kinase inhibitors. BMJ Case Reports 2021; 14(9): e243671 doi: 10.1136/bcr-2021-243671
|
| 13 |
Zafar Iqbal, Muhammad Absar, Tanveer Akhtar, Aamer Aleem, Abid Jameel, Sulman Basit, Anhar Ullah, Sibtain Afzal, Khushnooda Ramzan, Mahmood Rasool, Sajjad Karim, Zeenat Mirza, Mudassar Iqbal, Maryam AlMajed, Buthinah AlShehab, Sarah AlMukhaylid, Nouf AlMutairi, Nawaf Al-anazi, Muhammad Farooq Sabar, Muhammad Arshad, Muhammad Asif, Masood Shammas, Amer Mahmood. Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia. Biology 2021; 10(11): 1182 doi: 10.3390/biology10111182
|
| 14 |
Shikha Verma, Aditi Sharan. Unveiling the Biomarkers: Identifying Key Signatures for Cancer Hallmarks. EAI Endorsed Transactions on Pervasive Health and Technology 2024; 10 doi: 10.4108/eetpht.10.5649
|
| 15 |
Abdulbaki Yildirim, Hilal Akalin, Munis Dundar. Oncology: Genomics, Precision Medicine and Therapeutic Targets. 2023; : 25 doi: 10.1007/978-981-99-1529-3_2
|
| 16 |
Qianan Li, Xinxin Ren, Ying Wang, Xiaoru Xin. CircRNA: a rising star in leukemia. PeerJ 2023; 11: e15577 doi: 10.7717/peerj.15577
|
| 17 |
Sagar Sanjiv Desai, Febina Ravindran, Amey Panchal, Nishit Ojha, Sachin Jadhav, Bibha Choudhary. Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1100587
|
| 18 |
Ruggero Lasala, Fiorenzo Santoleri. Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature. British Journal of Clinical Pharmacology 2022; 88(5): 1999 doi: 10.1111/bcp.15147
|
| 19 |
Zahraa A. Abdulrazaq, Mushtak T.S. Al-Ouqaili, Nabeel M. Talib. The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study. Saudi Journal of Biological Sciences 2024; 31(1): 103882 doi: 10.1016/j.sjbs.2023.103882
|
| 20 |
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Yin Fai Lee, Manfredi Rizzo, Alaa A. Aljabali, Vijay Mishra, Yachana Mishra, Altijana Hromić-Jahjefendić, Murtaza M. Tambuwala. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia. Pathology - Research and Practice 2024; 254: 155161 doi: 10.1016/j.prp.2024.155161
|
| 21 |
Andriy Grafov, Ana Flávia da Silva Chagas, Alice de Freitas Gomes, Wessal Ouedrhiri, Pierfrancesco Cerruti, Maria Cristina Del Barone, Breno de Souza Mota, Carlos Eduardo de Castro Alves, Anny Maíza Vargas Brasil, Antonia Maria Ramos Franco Pereira, Gemilson Soares Pontes. A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles. Pharmaceutics 2024; 16(7): 874 doi: 10.3390/pharmaceutics16070874
|
| 22 |
Sadegh Rajabi, Shokoofe Noori, Mohammad Reza Ashrafi, Mahsa Azami Movahed, Shabnam Farzaneh, Afshin Zarghi. Naringenin enhances anti-proliferation effect of 1-ferrocenyl-3-(4-methylsulfonylphenyl) propen-1-one on two different cells via targeting calmodulin signaling pathway. Molecular Biology Reports 2022; 49(2): 1027 doi: 10.1007/s11033-021-06923-8
|
| 23 |
Kawthar Ali Radhi, Bassam Francis Matti, Israa Hussein Hamzah. The role of miRNA- 96 and miRNA-150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 2023; 36: 201166 doi: 10.1016/j.humgen.2023.201166
|
| 24 |
Nabaneet Majumder, Sayandeep Nath. A Study of Hematological Malignancies in Tripura Medical College & Dr. BRAM Teaching Hospital. Journal of Evolution of Medical and Dental Sciences 2021; 10(31): 2456 doi: 10.14260/jemds/2021/502
|
| 25 |
Sara Benchikh, Soro Somda Georgina Charlène, Amale Bousfiha, Lunda Razoki, Jamila Aboulfaraj, Latifa Zarouf, Adil El Hamouchi, Abderrahim Malki, Sanaa Nassereddine. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco. Annals of Hematology 2024; doi: 10.1007/s00277-024-05747-3
|
| 26 |
Praveen Sharma, Man Updesh Singh Sachdeva, Shano Naseem, Sreejesh Sreedharanunni, Reena Das, Pankaj Malhotra, Neelam Varma. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia. International Journal of Laboratory Hematology 2022; 44(3): 518 doi: 10.1111/ijlh.13807
|
| 27 |
Aleena K S Arakaki, Frank Szulzewsky, Mark R Gilbert, Taranjit S Gujral, Eric C Holland. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Neuro-Oncology 2021; 23(Supplement_5): S4 doi: 10.1093/neuonc/noab183
|
| 28 |
Kawthar Ali Radhi, Israa Hussein Hamzah, Bassam Francis Matti. The role of miRNA -181C between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 2022; 34: 201128 doi: 10.1016/j.humgen.2022.201128
|
| 29 |
Macario Martínez-Castillo, Laura Gómez-Romero, Hugo Tovar, Irma Olarte-Carrillo, Anel García-Laguna, Gilberto Barranco-Lampón, Adrián De la Cruz-Rosas, Adolfo Martínez-Tovar, Araceli Hernández-Zavala, Emilio J. Córdova. Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia. Leukemia Research 2023; 131: 107325 doi: 10.1016/j.leukres.2023.107325
|